Sertraline Tablets

Award Notice Posted

Solicitation number
SPE2D2-26-D-0012
Agency
Awarded
to Exelan Pharmaceuticals Inc.
Set-aside
No set-aside

Opportunity facts

Contract number
SPE2D2-26-D-0012 Federal IDV award
Place of performance
Hauppauge, New York 11788, United States

Notice details come from SAM.gov. Updated .

About this opportunity

The Defense Logistics Agency (DLA) Troop Support Medical awarded contract SPE2D2-26-D-0012 to Exelan Pharmaceuticals Inc. on April 21, 2026, for the supply of sertraline tablets across multiple strengths (25mg, 50mg, and 100mg) and various package sizes (30, 60, 90, 100, 180, and 500-count bottles). The contract is valued at $22,510,720.70 and will extend over a five-year period consisting of a base year and four option years. Unit prices for the pharmaceutical products range from $0.75 to $11.93 per bottle depending on strength and quantity ordered. The sertraline tablets will be manufactured by InvaGen Pharmaceuticals, Inc., and distributed through designated Pharmaceutical Prime Vendors including AmerisourceBergen Drug Corporation, Cardinal Health Inc., and McKesson Corp.

Notice text

SPE2D2-26-D-0012 Sertraline Tablets Follow-On Award

Awarded contract SPE2D2-26-D-0012 to EXELAN PHARMACEUTICALS INC for 22510720.70 on 2026-04-21.

Files

File Type Posted
SPE2D2-26-D-0012 Award Signed.pdf PDF

Notice history

Notice Type Posted
This notice Award Award Notice
Sertraline Tablets Latest solicitation Solicitation
Sertraline Tablets Original Pre-Solicitation

On GovTribe

Work this opportunity

  • Track it in your pipeline
  • Find teaming partners
  • Similar opportunities
  • Ask GovTribe AI about this opportunity